Inform, Empower, Connect


Trial Status
I am interested in
Trial Phase ID/ NCT Number
Trial Name Status Phase Country City
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

KB707-01 is a Phase 1, open-label, multicenter, dose escalation and expansion study to evaluate the safety and tolerability of KB707 in adults with locally advanced or metastatic solid tumors who have...

Not yet recruiting Early Phase 1,
A Single-arm, Open-label, Single-center Prospective Study of Fruquintinib Combined With Envafolimab in the Treatment of Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma

Many osteosarcomas are cured with a variety of combined chemotherapy and surgery, but a significant number will still relapse.VEGF promotes an immunosuppressive microenvironment and contributes to imm...

Not yet recruiting Phase 2,
A Clinical Study of Surufatinib Combined With Chemotherapy as Neoadjuvant Treatment in Osteosarcoma

This phase II study aims to explore the tumor necrosis rate in osteosarcoma patients treated with a neoadjuvant regimen of surufatinib combined with chemotherapy.

Not yet recruiting Phase 2,
Soluble B7-H3 as a Biomarker for Osteosarcoma

A marker called B7-H3 has been associated with cancer. This marker could be used to monitor the effectiveness of cancer treatment. In this trial, osteosarcoma patients will have blood tests before and...

Recruiting China, Beijing,
Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate

This trial will look at the care that cancer patients get while on high-dose methotrexate (a chemotherapy drug) and the effect the drug has on the kidneys and their treatment regimen. The researchers ...

Recruiting France, Italy, Spain, Marseille, Monza, Barcelona, Córdoba,
Investigating Cognitive Impairment in Young Patients With Cancer Prospectively

This trial will investigate the brain function of children, adolescents and young adults during and after chemotherapy treatment. It will test cognitive skills such as memory and attention, the brain'...

Recruiting Denmark, Copenhagen,
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors

This trial will assess the safety and effectiveness of a drug called an oncolytic virus in sarcoma. This includes people with osteosarcoma that have returned or not responded to standard treatment.

Recruiting Early Phase 1, China, Xi'an,
ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas

This trial will test the effectiveness of a drug called HS-20093 in treating sarcoma. This includes osteosarcoma. There are two phases to this trial. People in the first part of the trial will be assi...

Recruiting Phase 2, China, Beijing,
Extracorporeal Shock Wave Therapy on Osteoblast-Like Cells In- Vitro Study

The idea of treating different deformities or diseases in the maxillofacial region with Extracorporeal Shockwave Therapy (ESWT) has recently become popular. It has been widely used in medical practice...

Completed Not Applicable, India, Bengaluru,
3D Printed Personalized Extendable Prosthesis

The goal of this type of observational study is to investigate the preliminary effect of 3D printed personalized extendable prosthesis replacement on limb salvage in children with osteosarcoma. The ma...

Completed China, Chongqing,


  • ONTEX is intended to supplement, not replace, your healthcare team. Patients should always discuss a clinical trial with their healthcare team. If a patient is eligible for a trial the trial team will be able to provide more in-depth information about the trial so the patient can make an informed decision before taking part. Trial information has been sourced from The content is then reviewed weekly by the Osteosarcoma Now team. All the trials also have a patient-friendly summary and key information section written by the team at Osteosarcoma Now. We have also included a description of the medications being used in the trial and summarised the inclusion and exclusion criteria in the ‘who is this trial (not) for’ sections. To the best of our knowledge the clinical trial database is up-to-date and accurate.However, we cannot assume any liability for the accuracy or completeness of the information.